AI/ML medical device market to reach USD 26.87 billion 

The artificial intelligence/machine learning medical devicemarket is estimated to reach over USD 26.87 billion by 2031, exhibiting a CAGR of 22.72% during the forecast period.

The market for medical devices with AI/ML capabilities is very fragmented, and every year, more goods with FDA and CE marks are authorized. This sector still has a significant amount of growth potential due to ongoing technological developments and investments in healthcare AI. The global market for artificial intelligence/machine learning medical devices may benefit from the development of diagnostic accuracy and productivity-enabling AI-based medical equipment.

After the Covid-19 pandemic, the market is expected to grow significantly, mostly due to the epidemic’s increased need for AI-based remedies. The market will expand because of increased research into products that employ artificial intelligence, advancements in deep learning and machine learning algorithms, the introduction of new goods to the marketplace, the creation of local firms, and the rising usage of AI-based products for therapeutic reasons.

Market dynamics:
Drivers
Identifying Diseases and Diagnosis as one of the most important uses of this technology in healthcare is detecting and diagnosing ailments and illnesses that can occasionally be challenging to recognize. This might include everything from genetic illnesses to early-stage tumors that are difficult to detect. IBM Watson Genomics is a well-known example of how merging cognitive computing with genome-based tumor sequencing may help with cancer detection. A leading biopharmaceutical company called Berg uses AI to create medicinal solutions for problems like cancer. Medical Imaging Diagnosis: Computer vision is a cutting-edge method that blends ML and deep learning. The Microsoft Inner Eye initiative, which focuses on image diagnostic tools for image analysis, has approved this.

Challenges:
The following difficulties are predicted to provide additional restrictions for the market. Lack of transparency and privacy worries about data sharing cause cybersecurity worries and impede the use of AI in healthcare. Furthermore, the use of AI-enabled solutions needs to be improved by issues with the identification and minimization of bias in AI algorithms, which raises questions about the accuracy of diagnosis.

Regional trends:
Due to the increased adoption of healthcare IT solutions, the availability of funding for the development of AI capabilities, and the region’s well-established healthcare infrastructure, North America is expected to lead the market over the course of the projected period. The market in Asia Pacific is anticipated to develop in the near future due to factors including expanding healthcare infrastructure, an increase in the number of AI start-ups, and a significant rise in the adoption of cutting-edge technologies. InsightAce Analytic